Home Health Vital Signs: Progress Toward Eliminating HIV as a Global Public ..

Vital Signs: Progress Toward Eliminating HIV as a Global Public ..

0
Vital Signs: Progress Toward Eliminating HIV as a Global Public ..

[ad_1]

Helen M. Chun, MD1,*; Emilio Dirlikov, PhD1,*; Mackenzie Hurlston Cox, MSPH1; Michelle Williams Sherlock, MPH1; Yaa Obeng-Aduasare, MPH1; Kimi Sato, MPH1; Andrew C. Voetsch, PhD1; Abraham D. Ater, DrPH1; Erin Rottinghaus Romano, PhD1; Hank Tomlinson, PhD1; Surbhi Modi, MD1; Angeli Achrekar, DrPH2; John Nkengasong, PhD2; CDC Global HIV Working Group (View author affiliations)

View suggested citation

Summary

What is already identified about this subject?

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) started offering HIV antiretroviral remedy (ART) worldwide in 2004. Through viral load suppression, efficient ART improves well being outcomes and prevents transmission.

What is added by this report?

By 2022, roughly 20 million individuals with HIV an infection in 54 nations obtained PEPFAR-supported ART (62% CDC-supported); this quantity represents a rise of 300-fold from 66,6550 in 2004. During 2015–2022, viral load suppression charges elevated from 80% to 95% amongst those that obtained testing.

What are the implications for public well being observe?

To remove HIV as a worldwide public well being risk, achievements have to be sustained and expanded to achieve all subpopulations. PEPFAR stays dedicated to tackling HIV whereas strengthening public well being methods and world well being safety.

Altmetric:
Citations:
Views:

Views equals web page views plus PDF downloads

This figure is a visual that says, “People on lifesaving HIV treatment through PEPFAR rose 300 times in under 20 years. Eliminate HIV as a global public health threat by sustaining and expanding achievements.” There is a bar graph showing that the number of people globally on PEPFAR in 2004 was 66,500 and more than 20 million in 2022.

Introduction: In 2004, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), with CDC as a significant U.S. authorities implementing company, started offering HIV antiretroviral remedy (ART) worldwide. Through suppression of HIV viral load, efficient ART reduces morbidity and mortality amongst individuals with HIV an infection and prevents vertical and sexual transmission.

Methods: To describe program affect, knowledge have been analyzed from all PEPFAR packages and from six nations which have carried out nationally consultant Population-based HIV Impact Assessment (PHIA) surveys, together with PEPFAR programmatic knowledge on the variety of individuals with HIV an infection receiving PEPFAR-supported ART (2004–2022), charges of viral load protection (the proportion of eligible individuals with HIV an infection who obtained a viral load take a look at) and viral load suppression (proportion of individuals who obtained a viral load take a look at with <1,000 HIV copies per mL of blood) (2015–2022), and inhabitants viral load suppression charges in six nations that had two PHIA surveys carried out throughout 2015–2021. To assess well being system strengthening, knowledge on workforce and laboratory methods have been analyzed.

Results: By September 2022, roughly 20 million individuals with HIV an infection in 54 nations have been receiving PEPFAR-supported ART (62% CDC-supported); this quantity elevated 300-fold from the 66,550 reported in September 2004. During 2015–2022, viral load protection greater than tripled, from 24% to 80%, and viral load suppression elevated from 80% to 95%. Despite will increase in viral load suppression charges and well being system strengthening investments, variability exists in viral load protection amongst some subpopulations (kids aged <10 years, males, pregnant ladies, males who’ve intercourse with males [MSM], individuals in prisons and different closed settings [persons in prisons], and transgender individuals) and in viral load suppression amongst different subpopulations (pregnant and breastfeeding ladies, individuals in prisons, and individuals aged <20 years).

Conclusions and implications for public well being observe: Since 2004, PEPFAR has scaled up efficient ART to roughly 20 million individuals with HIV an infection in 54 nations. To remove HIV as a worldwide public well being risk, achievements have to be sustained and expanded to achieve all subpopulations. CDC and PEPFAR stay dedicated to tackling HIV whereas strengthening public well being methods and world well being safety.

Introduction

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) was introduced in January 2003 and stays the most important dedication by any nation to deal with a single illness. PEPFAR’s core goal is to deal with well being inequities in entry to HIV companies. The preliminary objective was to forestall 7 million infections, deal with 2 million individuals, and supply humane look after individuals affected by AIDS and for kids orphaned by AIDS. At the time, roughly 30 million individuals with HIV an infection have been estimated to dwell on the African continent, together with 3 million kids and adolescents aged <15 years; nevertheless, solely 50,000 have been receiving antiretroviral remedy (ART).§ Since 2004, PEPFAR has supported companion governments’ growth of ART supply whereas strengthening well being methods. Through viral load suppression, efficient ART reduces morbidity and mortality amongst individuals with HIV an infection (1); it additionally prevents vertical transmission from moms with HIV an infection to their infants if the mom is on ART and the HIV-exposed toddler receives prophylaxis; and prevents sexual transmission when viral load is undetectable (<200 copies per mL of blood) (25).

PEPFAR, led and coordinated by the U.S. Department of State, makes use of a whole-of-government strategy for world HIV/AIDS response, carried out by seven U.S. authorities departments and businesses, together with CDC. As the U.S. company answerable for defending public well being, CDC {couples} its core space investments in public well being workforce growth, surveillance, and laboratory capability with scientific and technical experience and data-driven approaches to struggle the worldwide HIV epidemic and different threats to world well being safety.**

PEPFAR helps the Sustainable Development Goals and the Joint United Nations Programme on HIV/AIDS’ (UNAIDS) fast-track technique to finish the AIDS epidemic as a worldwide risk by 2030: that 95% of individuals with HIV an infection know their standing, that 95% of these with identified standing obtain ART, and that 95% of these receiving ART obtain viral load suppression.†† Worldwide in 2021, an estimated 38.4 million individuals had HIV an infection; 650,000 AIDS-related deaths and 1.5 million new infections occurred.§§ An estimated 28.7 million individuals with HIV an infection have been receiving ART, and amongst these receiving ART, an estimated 92% had suppressed viral masses. To assess PEPFAR-supported program affect and well being system–strengthening investments, programmatic knowledge from all PEPFAR packages and survey knowledge for six nations with a couple of Population-based HIV Impact Assessment (PHIA) survey have been analyzed.¶¶

Methods

To describe program affect, PEPFAR Monitoring, Evaluation, and Reporting*** programmatic knowledge have been analyzed by age, intercourse, and subpopulation (pregnant or breastfeeding ladies and key populations, together with feminine intercourse staff, males who’ve intercourse with males (MSM), transgender individuals, individuals who inject medication, and individuals in prisons), and proportion of CDC contribution; analyses have been stratified by fiscal yr (October–September).††† Before October 2018, individuals with HIV an infection receiving PEPFAR-supported ART have been outlined as individuals at present receiving ART and for whom ≤90 days had elapsed after lacking a scheduled ART pickup; in October 2018, this definition modified to individuals at present receiving ART for whom ≤28 days had elapsed after lacking a scheduled ART pickup. A proxy charge for viral load protection was calculated as the proportion of individuals with HIV an infection receiving ART for ≥6 months with documented receipt of a viral load take a look at throughout the earlier 12 months. As an indicator of ART effectiveness, viral load suppression was outlined as <1,000 HIV copies per mL of blood, and the viral load suppression charge was calculated because the variety of individuals with HIV an infection with viral load suppression amongst those that obtained a viral load take a look at. Using knowledge from the PEPFAR-supported, CDC-led PHIA surveys, inhabitants viral load suppression charges by intercourse and age group (15–24, 25–34, 35–49, and ≥50 years) have been analyzed for six nations (Eswatini, Lesotho, Malawi, Uganda, Zambia, and Zimbabwe) that accomplished two surveys throughout 2015–2021.§§§

PEPFAR Monitoring, Evaluation, and Reporting knowledge have been analyzed to explain well being system strengthening investments. The workforce contains the variety of well being care staff (together with lay, scientific, pharmacy, and laboratory staff) who present HIV- or tuberculosis (TB)-related prevention, remedy, or different HIV-related companies in group, clinic, or different settings. Molecular testing capability was outlined because the existence of a facility with devoted infrastructure and workers members educated to conduct HIV early toddler analysis, viral load, or TB molecular diagnostic testing. Laboratory steady high quality enchancment enrollment was outlined as participation in actions geared toward making certain diagnostic accuracy and reliability supported by a acknowledged laboratory steady high quality enchancment program. Accreditation was outlined as reaching the best normal of scientific laboratory high quality as assessed by a nationally, regionally, or internationally acknowledged accrediting physique. This exercise was reviewed by CDC and carried out per relevant federal legislation and CDC coverage.¶¶¶

Results

During 2004–2022, the variety of individuals with HIV an infection receiving PEPFAR-supported ART elevated 300-fold, from 66,550 to twenty,166,110, in 54 nations (Figure 1). During 2015–2022, the annual variety of individuals with HIV an infection who obtained a viral load take a look at elevated 605%, from 2,109,749 to 14,875,130, and the general viral load protection charge elevated 233%, from 24% (2,109,749 of 8,806,300 eligible individuals who obtained a viral load take a look at) to 80% (14,875,130 of 18,573,406) (Figure 2) (Table 1). During 2017–2022, viral load protection charges elevated to roughly 75% amongst ladies, males, and individuals aged <10, 10–19, and ≥20 years; amongst pregnant ladies, viral load protection elevated 72%, from 18% to 31%. During 2020–2022, viral load protection elevated from 70% to 85% amongst feminine intercourse staff, from 62% to 83% amongst individuals who inject medication, and from 64% to 78% amongst MSM. Among transgender individuals, viral load protection decreased 6%, from 71% to 67%, and amongst individuals in prisons, protection decreased 24%, from 75% to 57%.

During 2015–2022, the viral load suppression charge amongst these receiving testing elevated from 80% (1,691,232 individuals with viral load suppression of two,109,749 who obtained a viral load take a look at) to 95% (14,146,647 of 14,875,130) (Figure 2). During 2017–2022, the viral load suppression charge elevated amongst ladies, males, individuals aged <10, 10–19, and ≥20 years, pregnant ladies, and breastfeeding ladies. Males, females, and people aged ≥20 years reached viral load suppression charges of ≥95% in 2022 (Table 1). By 2022, the viral load suppression charge amongst feminine intercourse staff, MSM, transgender individuals, and individuals who inject medication reached ≥95%, however amongst individuals in prisons, remained unchanged, at 93%.

PHIA survey outcomes demonstrated elevated inhabitants viral load suppression charges in all six assessed nations, with total viral load suppression charges within the first and second surveys starting from 59.2% (Zambia) to 73.1% (Eswatini) and 75.4% (Uganda) to 88.6% (Eswatini), respectively (Table 2). Across all surveys, with few exceptions, inhabitants viral load suppression charges have been greater in older than in youthful individuals, and better in ladies than in males.

In 2022, the PEPFAR-supported workforce included 371,760 well being care staff in roughly 70,000 group, clinic, or different settings. During 2017–2022, the variety of PEPFAR-supported amenities with a molecular laboratory elevated by 115%, from 926 to 1,995; the variety of PEPFAR-supported amenities with a number of laboratory enrolled in a steady high quality enchancment program elevated by 112%, from 795 to 1,687; and those who have been accredited elevated by 194%, from 103 to 303.

In 2010, roughly one half of individuals with HIV an infection receiving PEPFAR-supported ART obtained companies by way of CDC implementing companions (Figure 1). By September 2022, CDC implementing companions supported 62% (12,566,736 of 20,166,110 individuals with HIV an infection receiving PEPFAR-supported ART) of the PEPFAR whole. Among the entire PEPFAR-supported workforce in 2022, 42% have been supported by way of CDC implementing companions.

Discussion

The cumulative program affect of PEPFAR amongst 54 nations reached roughly 20.2 million individuals with HIV an infection with lifesaving ART by September 2022, a 300-fold improve from 2004. PEPFAR-supported ART is efficient, as demonstrated by program knowledge indicating that the UNAIDS goal for viral load suppression was achieved in 2022, and by PHIA survey knowledge indicating elevated viral load suppression charges on the inhabitants stage (i.e., not restricted to individuals with HIV an infection receiving PEPFAR-supported ART). By offering efficient ART, PEPFAR’s investments have helped avert new HIV infections (6) and have led to sustained declines in all-cause mortality.**** For instance, in Uganda, the primary PEPFAR-supported nation, ART scale-up since 2004 has helped to avert an estimated 500,000 infections, together with roughly 230,000 infections amongst HIV-exposed infants, and 600,000 HIV-related deaths (7). In Eswatini, nationwide HIV incidence decreased by almost one half and viral load suppression doubled throughout 2011–2016 (8).

PEPFAR program affect is based on strengthened well being methods. Improvements in laboratory capability, together with molecular testing and steady high quality enchancment actions described on this report, have supported the total HIV cascade of care (9), together with correct HIV analysis, remedy, and viral load monitoring of ART effectiveness. Investments replicate PEPFAR’s dedication to native public well being system strengthening for broader pandemic preparedness and response. Under PEPFAR’s present 5-year technique,†††† the United States goals to remove the HIV/AIDS pandemic as a public well being risk by 2030, whereas sustainably strengthening public well being methods.

Through PEPFAR, CDC is on the forefront of world ART scale-up efforts. CDC receives roughly 50% of PEPFAR funding for HIV remedy and helps roughly 60% of all individuals receiving ART by way of PEPFAR. The PEPFAR-supported CDC-led PHIA surveys have offered rigorous estimates of essential HIV indicators by age group, intercourse, and subnational geographic items. Other PEPFAR investments achieved by way of CDC have strengthened surveillance methods, akin to well being and laboratory data methods for affected person and program monitoring, in addition to HIV case reporting. The PEPFAR laboratory steady high quality enchancment program (Strengthening Laboratory Management Toward Accreditation§§§§) has offered sensible instruments for resource-limited settings to enhance high quality administration methods and put together laboratories for accreditation¶¶¶¶ (10). CDC gives management in using a number of knowledge sources to repeatedly determine gaps in HIV service supply for coverage and program motion (11,12).

Beyond HIV, PEPFAR investments in public well being system strengthening have had further advantages, together with enhancing world well being safety. For instance, in the course of the COVID-19 pandemic, PEPFAR-supported nations demonstrated the resilience of PEPFAR investments by defending and advancing HIV response positive aspects (13,14), whereas additionally responding to COVID-19. In Nigeria, an ART surge in 9 states supported by CDC by way of PEPFAR quickly elevated the entire variety of individuals with HIV an infection receiving ART by 26% (110,815) throughout April–September 2020 alone (15,16). PEPFAR investments have been leveraged for public well being emergency response. Workforce investments have educated and deployed giant numbers of well being care staff not solely to forestall, diagnose, and deal with HIV and supply high quality look after individuals with HIV an infection, but in addition to determine, monitor, and include different well being threats akin to cholera, Ebola virus illness, and COVID-19.***** During April 2020–March 2021, a complete of 109 PEPFAR-supported centralized HIV viral load and early toddler analysis laboratories and 138 decentralized HIV and TB websites reported conducting roughly 3.4 million SARS-CoV-2 exams in 16 nations (17).

Despite these achievements, 10 million individuals with HIV an infection worldwide (in nations with and with out PEPFAR assist) weren’t receiving ART in 2021, and gaps exist amongst sure subpopulations. Global HIV management can’t be achieved with out prioritizing well being fairness. For instance, though total viral load protection charges have elevated over time, charges have been decrease amongst kids aged <10 years, males, pregnant ladies, MSM, individuals in prisons, and transgender individuals. Similarly, whereas total viral load suppression charges reached the UNAIDS goal of 95% of individuals with HIV an infection receiving ART, charges have been decrease amongst pregnant and breastfeeding ladies and individuals in prisons, and far decrease for individuals aged <20 years, together with kids and adolescents with HIV an infection. Results from PHIA surveys additional spotlight decrease viral load suppression charges amongst youthful age teams and amongst males in contrast with ladies. Stigma and discrimination stay essential limitations to well being fairness. In sub-Saharan Africa, for instance, HIV prevalence amongst MSM and transgender ladies is considerably greater than it’s within the basic inhabitants (18). Understanding the basis causes together with structural determinants of well being for the noticed variations and addressing potential elements resulting in well being disparities is important to remove HIV as a worldwide public well being risk.

The findings on this report are topic to at the very least six limitations. First, indicator definitions and the methods to gather and report knowledge have developed over time, which could have affected knowledge high quality and outcomes noticed. Second, the nations, variety of websites reporting, adjustments in nationwide HIV tips (i.e., prevention, remedy, ART initiation standards, really helpful ART regimens, and monitoring), and the power for individuals with HIV an infection to entry companies at any website have additionally developed, which could have affected outcomes noticed. Third, misclassification of sufferers in sure subpopulations might need occurred if this data was not disclosed and captured by medical information. Fourth, viral load protection analyses used combination program knowledge, and as such, reported viral load proxy protection charges may differ from precise viral load protection charges. Fifth, as a result of some amenities might need a couple of laboratory, the variety of laboratories might need been underreported. Finally, programmatic knowledge can’t be immediately in contrast with PHIA outcomes, that are derived by way of consultant sampling strategies.

Since 2004, PEPFAR has scaled up ART to roughly 20 million individuals with HIV an infection worldwide, managing a continual illness at an unprecedented stage whereas strengthening public well being methods by way of workforce, surveillance, and laboratory capability investments. To remove HIV as a worldwide public well being risk, achievements in HIV companies have to be sustained and expanded to achieve all subpopulations. PEPFAR stays dedicated to supporting companion governments to remove HIV as a worldwide public well being risk whereas strengthening public well being methods and world well being safety.

Acknowledgments

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) companion governments; civil society organizations; website workers members; implementing companions; PEPFAR interagency viral load and early toddler analysis group of observe; Population-based HIV Impact Assessment assist groups (Eswatini, Lesotho, Malawi, Uganda, Zambia, and Zimbabwe); Division of Global HIV and TB, Center for Global Health, CDC.

CDC Global HIV Working Group

Simon Agolory, CDC; Josef Amann, CDC; Brittney Baack, CDC; Stephanie Behel, CDC; Anand Date, CDC; Jeff Hanson, CDC; William P. Killam, CDC; Hetal Patel, CDC; Sadhna Patel, CDC; Rituparna Pati, CDC; Laura Porter, CDC; Alicia Warner, CDC; Tadesse Wuhib, CDC; Clement Zeh, CDC; Ana Carolina Faria E Silva Santelli, CDC Brazil Country Office; Giselle Guevara, CDC Caribbean Regional Office; Rosa Elena Morales, CDC Central America Regional Office; Alexandre Kunumboa Ekra, CDC Côte d’Ivoire Country Office; Francois Kitenge, CDC Democratic Republic of the Congo Country Office; Luis Bonilla, CDC Dominican Republic Country Office; Sikhathele Mazibuko, CDC Eswatini Country Office; Tekeste Damena, CDC Ethiopia Country Office; Patrice Joseph, CDC Haiti Country Office; Sunita Upadhyaya, CDC India Country Office; Indira Aitmagambetova, CDC Kazakhstan Country Office; Jane Mwangi, CDC Kenya Country Office; Nazira Usmanova, CDC Kyrgzstan Country Office; Douangchanh Xaymounvong, CDC Laos Country Office; Mugyenyi Asiimwe, CDC Lesotho Country Office; Maida Alice, CDC Malawi Country Office; Gillian Jessina Masamha, CDC Mozambique Country Office; Gram Mutandi, CDC Namibia Country Office; Solomon Odafe, CDC Nigeria Country Office; Lacson Romel, CDC Philippines Country Office; Canisious Musoni, CDC Rwanda Country Office; Mary Mogashoa, CDC South Africa Country Office; Alex Bolo, CDC South Sudan Country Office; Aziz Nabidzhonov, CDC Tajikistan Country Office; George Mgomella, CDC Tanzania Country Office; Rangsima Lolekha, CDC Thailand Country Office; Stella Alamo-Talisuna, CDC Uganda Country Office; Nataliya Podolchak, CDC Ukraine Country Office; Chi Okay Nguyen, CDC Vietnam Country Office; Silas Quaye, CDC West Africa Regional Program Country Office; Annie Mwila, CDC Zambia Country Office; Ponesai Nyika, CDC Zimbabwe Country Office.


References

  1. Braitstein P, Brinkhof MW, Dabis F, et al.; ART Cohort Collaboration (ART-CC) teams. Mortality of HIV-1-infected sufferers within the first yr of antiretroviral remedy: comparability between low-income and high-income nations. Lancet 2006;367:817–24. https://doi.org/10.1016/S0140-6736(06)68337-2 PMID:16530575
  2. Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Antiretrovirals for decreasing the chance of mother-to-child transmission of HIV an infection. Cochrane Database Syst Rev 2011;(7):CD003510. https://doi.org/10.1002/14651858.CD003510.pub3 PMID:21735394
  3. Cohen MS, Chen YQ, McCauley M, et al.; HPTN 052 Study Team. Antiretroviral remedy for the prevention of HIV-1 transmission. N Engl J Med 2016;375:830–9. https://doi.org/10.1056/NEJMoa1600693 PMID:27424812
  4. Rodger AJ, Cambiano V, Bruun T, et al.; PARTNER Study Group. Risk of HIV transmission by way of condomless intercourse in serodifferent homosexual {couples} with the HIV-positive companion taking suppressive antiretroviral remedy (PARTNER): closing outcomes of a multicentre, potential, observational research. Lancet 2019;393:2428–38. https://doi.org/10.1016/S0140-6736(19)30418-0 PMID:31056293
  5. Bavinton BR, Pinto AN, Phanuphak N, et al.; Opposites Attract Study Group. Viral suppression and HIV transmission in serodiscordant male {couples}: a world, potential, observational, cohort research. Lancet HIV 2018;5:e438–47. https://doi.org/10.1016/S2352-3018(18)30132-2 PMID:30025681
  6. Heaton LM, Bouey PD, Fu J, et al. Estimating the affect of the US President’s Emergency Plan for AIDS Relief on HIV remedy and prevention programmes in Africa. Sex Transm Infect 2015;91:615–20. https://doi.org/10.1136/sextrans-2014-051991 PMID:26056389
  7. Dirlikov E, Kamoga J, Talisuna SA, et al.; PEPFAR Uganda. Scale-up of HIV antiretroviral remedy and estimation of averted infections and HIV-related deaths—Uganda, 2004–2022. MMWR Morb Mortal Wkly Rep 2023;72:90–4. https://doi.org/10.15585/mmwr.mm7204a2 PMID:36701255
  8. Nkambule R, Philip NM, Reid G, et al. HIV incidence, viremia, and the nationwide response in Eswatini: two sequential population-based surveys. PLoS One 2021;16:e0260892. https://doi.org/10.1371/journal.pone.0260892 PMID:34855890
  9. Medland NA, McMahon JH, Chow EP, Elliott JH, Hoy JF, Fairley CK. The HIV care cascade: a scientific overview of knowledge sources, methodology and comparability. J Int AIDS Soc 2015;18:20634. https://doi.org/10.7448/IAS.18.1.20634 PMID:26626715
  10. Yao Okay, Maruta T, Luman ET, Nkengasong JN. The SLMTA programme: remodeling the laboratory panorama in growing nations. Afr J Lab Med 2014;3:194. https://doi.org/10.4102/ajlm.v3i2.194 PMID:26752335
  11. Justman JE, Mugurungi O, El-Sadr WM. HIV inhabitants surveys—bringing precision to the worldwide response. N Engl J Med 2018;378:1859–61. https://doi.org/10.1056/NEJMp1801934 PMID:29768142
  12. Birx D, Zaidi I. Forward: measuring progress towards epidemic management. J Acquir Immune Defic Syndr 2021;87(Suppl 1):S1. https://doi.org/10.1097/QAI.0000000000002700 PMID:34166306
  13. Fisher KA, Patel SV, Mehta N, et al.; PEPFAR Strategic Information Study Group. Lessons discovered from programmatic positive aspects in HIV service supply in the course of the COVID-19 pandemic—41 PEPFAR-supported nations, 2020. MMWR Morb Mortal Wkly Rep 2022;71:447–52. https://doi.org/10.15585/mmwr.mm7112a2 PMID:35324881
  14. Bachanas PJ, Chun HM, Mehta N, et al. Protecting the positive aspects: evaluation of HIV remedy and repair supply programme knowledge and interventions carried out in 19 African nations throughout COVID-19. J Int AIDS Soc 2022;25:e26033. https://doi.org/10.1002/jia2.26033 PMID:36419346
  15. Boyd AT, Jahun I, Dirlikov E, et al. Expanding entry to HIV companies in the course of the COVID-19 pandemic—Nigeria, 2020. AIDS Res Ther 2021;18:62. https://doi.org/10.1186/s12981-021-00385-5 PMID:34538268
  16. Dirlikov E, Jahun I, Odafe SF, et al.; CDC Nigeria ART Surge Team. Rapid scale-up of an antiretroviral remedy program earlier than and in the course of the COVID-19 pandemic—9 states, Nigeria, March 31, 2019–September 30, 2020. MMWR Morb Mortal Wkly Rep 2021;70:421–6. https://doi.org/10.15585/mmwr.mm7012a3 PMID:33764965
  17. Romano ER, Sleeman Okay, Hall-Eidson P, et al. Contribution of PEPFAR-supported HIV and TB molecular diagnostic networks to COVID-19 testing preparedness in 16 nations. Emerg Infect Dis 2022;28:S59–68. https://doi.org/10.3201/eid2813.220789 PMID:36502414
  18. Kloek M, Bulstra CA, van Noord L, Al-Hassany L, Cowan FM, Hontelez JAC. HIV prevalence amongst males who’ve intercourse with males, transgender ladies and cisgender male intercourse staff in sub-Saharan Africa: a scientific overview and meta-analysis. J Int AIDS Soc 2022;25:e26022. https://doi.org/10.1002/jia2.26022 PMID:36419343
Return to your place in the textFIGURE 1. Cumulative variety of individuals with HIV an infection receiving antiretroviral remedy supported by the U.S. President’s Emergency Plan for AIDS Relief,* by CDC and different businesses — worldwide,§ fiscal years 2004–2022
The figure is a histogram showing the cumulative number of persons with HIV infection receiving antiretroviral therapy worldwide, supported by the U.S. President’s Emergency Plan for AIDS Relief, by CDC and other agencies during fiscal years 2004–2022.

Abbreviations: ART = antiretroviral remedy; PEPFAR = U.S. President’s Emergency Plan for AIDS Relief.

* Data on assist offered by CDC and different PEPFAR businesses accessible for fiscal years 2010–2022.

PEPFAR businesses embody the U.S. Agency for International Development, the U.S. Department of Health and Human Services and its businesses (CDC, Health Resources and Service Administration, and National Institutes of Health), the U.S. Department of Defense, the Peace Corps, the U.S. Department of Labor, the U.S. Department of Commerce, and the U.S. Department of the Treasury.

§ As of September 30, 2022: Angola, Benin, Botswana, Brazil, Burkina Faso, Burma, Burundi, Cameroon, Colombia, Cote d’Ivoire, Democratic Republic of the Congo, Dominican Republic, El Salvador, Eswatini, Ethiopia, Ghana, Guatemala, Haiti, Honduras, India, Indonesia, Jamaica, Kazakhstan, Kenya, Kyrgyzstan, Laos, Lesotho, Liberia, Malawi, Mali, Mozambique, Namibia, Nepal, Nicaragua, Nigeria, Panama, Papua New Guinea, Peru, Philippines, Rwanda, Senegal, Sierra Leone, South Africa, South Sudan, Tajikistan, Tanzania, Thailand, Togo, Trinidad and Tobago, Uganda, Ukraine, Vietnam, Zambia, and Zimbabwe.

Fiscal years are October–September.

Return to your place in the textFIGURE 2. Number of individuals with HIV an infection receiving antiretroviral remedy supported by the U.S. President’s Emergency Plan for AIDS Relief with a viral load take a look at,* viral load proxy protection charge, and viral load suppression charge§ — worldwide, fiscal years 2015–2022**
The figure is a histogram showing the number of persons with HIV infection receiving antiretroviral therapy worldwide, supported by the U.S. President’s Emergency Plan for AIDS Relief with a viral load test, viral load proxy coverage rate, and viral load suppression rate during fiscal years 2015–2022.

Abbreviations: ART = antiretroviral remedy; PEPFAR = U.S. President’s Emergency Plan for AIDS Relief.

* Viral load take a look at consequence documented within the affected person report or laboratory data system.

Proxy viral load protection charge was calculated as the proportion of individuals with HIV an infection receiving ART for ≥6 months with documented receipt of a viral load take a look at throughout the previous 12 months.

§ Viral load suppression was outlined as <1,000 HIV copies per mL of blood; suppression charge was calculated because the variety of individuals with HIV an infection with viral load suppression amongst those that obtained a viral load take a look at.

As of September 30, 2022: Angola, Benin, Botswana, Brazil, Burkina Faso, Burma, Burundi, Cameroon, Colombia, Cote d’Ivoire, Democratic Republic of the Congo, Dominican Republic, El Salvador, Eswatini, Ethiopia, Ghana, Guatemala, Haiti, Honduras, India, Indonesia, Jamaica, Kazakhstan, Kenya, Kyrgyzstan, Laos, Lesotho, Liberia, Malawi, Mali, Mozambique, Namibia, Nepal, Nicaragua, Nigeria, Panama, Papua New Guinea, Peru, Philippines, Rwanda, Senegal, Sierra Leone, South Africa, South Sudan, Tajikistan, Tanzania, Thailand, Togo, Trinidad and Tobago, Uganda, Ukraine, Vietnam, Zambia, and Zimbabwe.

** Fiscal years are October–September.

TABLE 1. Summary of programmatic knowledge on viral load testing,* proxy viral load protection, and viral load suppression,§ by age group, intercourse, and subpopulation — worldwide, fiscal years 2015–2022Return to your place in the text
Characteristic (program fiscal years, 2015–2022) Baseline programmatic knowledge** Programmatic knowledge from September 30, 2022 Change§§ in VL proxy protection, baseline–2022, % Change¶¶ in VL suppression, baseline–2022, %
No. of eligible†† individuals receiving VL take a look at/whole eligible individuals VL proxy protection charge, % VL suppression charge, % No. of eligible†† individuals receiving VL take a look at/whole eligible individuals VL proxy protection charge, % VL suppression charge, %
Overall 2,109,749/8,806,300 24 80 14,875,130/18,573,406 80 95 233 19
Age group, yrs (2017–2022)
<10 147,143/313,426 47 67 249,530/314,058 79 84 68 25
10–19 240,705/496,053 49 68 620,686/729,305 85 88 73 29
≥20 3,649,299/8,403,258 43 86 13,941,086/17,202,330 81 96 88 12
Unknown*** 249,150/2,832,066 9 88 63,828/327,713 19 94 111 7
Sex††† (2017–2022)
Female 2,760,201/7,695,526 36 86 9,768,760/12,034,211 81 95 125 10
Male 1,339,638/4,029,411 33 84 5,106,370/6,539,195 78 95 136 13
Pregnant and breastfeeding ladies with HIV an infection§§§ (2017–2022)
Pregnant ladies 80,652/438,315 18 95 150,818/487,608 31 92 72 −3
Breastfeeding ladies 82,255 NA 85 399,082 NA 94 11
Key populations (2020–2022)
Female intercourse staff 58,378/83,095 70 93 199,435/233,652 85 97 21 4
Men who’ve intercourse with males 51,317/79,983 64 94 165,352/210,926 78 97 22 3
Persons in prisons and different enclosed settings 18,605/24,821 75 93 22,836/39,805 57 93 –24 0
Persons who inject medication 33,716/54,394 62 93 79,822/96,228 83 96 34 3
Transgender individuals 2,352/3,328 71 89 7,120/10,700 67 96 −6 8

Abbreviations: ART = antiretroviral remedy; NA = not relevant; PEPFAR = U.S. President’s Emergency Plan for AIDS Relief; VL = viral load.
* VL take a look at consequence documented within the affected person report or laboratory data system.
Proxy VL protection charge was calculated as the proportion of individuals with HIV an infection who obtained ART for ≥6 months with documented receipt of a VL take a look at throughout the previous 12 months.
§ VL suppression was outlined as <1,000 HIV copies per mL of blood; suppression charge was calculated because the variety of individuals with HIV an infection with VL suppression amongst those that obtained a VL take a look at.
Each attribute was calculated utilizing knowledge from the tip of the fiscal yr from which they have been accessible to the tip of fiscal yr 2022.
** The yr of comparability for every group various based mostly on the standard and availability of knowledge for analyses and is indicated within the row parentheses.
†† Eligible individuals are those that have obtained ART for ≥6 months, derived from the variety of individuals receiving PEPFAR-supported ART in the course of the two previous quarters.
§§ Calculated as ([VL coverage 2022 − VL coverage baseline]/VL protection baseline)*100.
¶¶ Calculated as ([VL suppression 2022 − VL suppression baseline]/VL suppression baseline)*100.
*** The worth for age unknown contains 327,713 individuals who obtained ART and have been eligible for a VL take a look at, reported in combination age teams solely (i.e., <15 years and ≥15 years). Because of the proxy nature of the indicator, knowledge reporting discrepancies for age group (<15 years and ≥15 years versus age disaggregates in ≤5-year age bands) is perhaps noticed.
††† PEPFAR indicators are disaggregated by biologic intercourse (male or feminine), the place relevant.
§§§ The variety of breastfeeding ladies receiving ART just isn’t reported in PEPFAR monitoring, analysis, and reporting.

TABLE 2. Population viral load suppression prevalence* outcomes from Population-based HIV Impact Assessment surveys in nations supported by the U.S. President’s Emergency Plan for AIDS Relief — six African nations, 2015–2021Return to your place in the text
Country, age group, yrs Population viral load suppression charge,% % Change from survey 1 to survey 2
Survey 1 Survey 2
Male Female Total Male Female Total Male Female Total
Eswatini
All ages 67.6 76.0 73.1 86.1 90.1 88.6 18.5 14.1 15.5
15–24 32.9 55.5 50.6 80.5 76.1 77.1 47.6 20.6 26.5
25–34 54.8 73.5 68.4 62.9 85.7 80.4 8.1 12.2 12.0
35–49 71.5 82.7 78.5 88.9 93.8 91.9 17.4 11.1 13.4
≥50 86.4 85.3 85.8 94.3 96.3 95.3 7.9 11.0 9.5
Lesotho
All ages 63.4 70.5 67.6 77.1 83.4 81.0 13.7 12.9 13.4
15–24 51.3 50.9 51.0 61.7 65.6 64.7 10.4 14.7 13.7
25–34 46.1 64.6 57.9 58.7 77.6 72.3 12.6 13.0 14.4
35–49 67.5 78.3 73.3 78.3 87.8 83.5 10.8 9.5 10.2
≥50 84.3 80.6 82.3 90.7 90.7 90.7 6.4 10.1 8.4
Malawi
All ages 60.9 73.1 68.3 85.5 88.4 87.3 24.6 15.3 19.0
15–24 37.2 49.7 46.0 75.0 73.2 73.8 37.8 23.5 27.8
25–34 48.2 70.1 62.9 74.0 82.6 80.1 25.8 12.5 17.2
35–49 66.0 78.5 73.2 87.6 92.7 90.8 21.6 14.2 17.6
≥50 73.7 81.6 78.0 90.9 93.0 92.0 17.2 11.4 14.0
Uganda
All ages 53.6 62.9 59.6 69.8 78.3 75.4 16.2 15.4 15.8
15–24 32.5 44.9 42.5 43.5 57.8 54.7 11.0 12.9 12.2
25–34 38.7 57.9 52.6 51.9 75.0 68.8 13.2 17.1 16.2
35–49 60.1 71.4 66.3 75.1 84.9 80.9 15.0 13.5 14.6
≥50 65.0 79.4 73.0 85.4 90.2 88.0 20.4 10.8 15.0
Zambia
All ages 57.2 60.4 59.2 85.5 86.6 86.2 28.3 26.2 27.0
15–24 36.7 33.6 34.3 70.1 71.2 70.9 33.4 37.6 36.6
25–34 36.7 56.1 50.4 72.6 83.4 81.0 35.9 27.3 30.6
35–49 61.8 70.8 66.9 87.7 89.9 89.1 25.9 19.1 22.2
≥50 79.7 73.5 76.6 93.0 91.7 92.3 13.3 18.2 15.7
Zimbabwe
All ages 54.1 63.8 59.8 73.0 79.8 77.3 18.9 16.0 17.5
15–24 40.1 47.9 45.3 49.2 66.2 60.6 9.1 18.3 15.3
25–34 36.2 54.2 48.7 52.4 70.7 65.7 16.2 16.5 17.0
35–49 55.8 70.5 63.9 76.6 82.4 80.2 20.8 11.9 16.3
≥50 71.6 78.8 75.1 84.5 91.0 88.1 12.9 12.2 13.0

* Viral load suppression was outlined as <1,000 copies per mL of blood; suppression charge was calculated because the variety of individuals with HIV an infection with viral load suppression amongst those that obtained a viral load take a look at.
Eswatini: survey 1 was carried out throughout 2016–2017, and survey 2 throughout 2021; Lesotho: survey 1 was carried out throughout 2016–2017, and survey 2 throughout 2020; Malawi: survey 1 was carried out throughout 2015–2016, and survey 2 throughout 2020–2021; Uganda: survey 1 was carried out throughout 2016–2017, and survey 2 throughout 2020–2021; Zambia: survey 1 was carried out throughout 2016, and survey 2 throughout 2021; and Zimbabwe: survey 1 was carried out throughout 2015–2016, and survey 2 throughout 2021.

Suggested quotation for this text: Chun HM, Dirlikov E, Cox MH, et al. Vital Signs: Progress Toward Eliminating HIV as a Global Public Health Threat Through Scale-Up of Antiretroviral Therapy and Health System Strengthening Supported by the U.S. President’s Emergency Plan for AIDS Relief — Worldwide, 2004–2022. MMWR Morb Mortal Wkly Rep. ePub: 14 March 2023. DOI: http://dx.doi.org/10.15585/mmwr.mm7212e1.


MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.

Use of commerce names and business sources is for identification solely and doesn’t suggest endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC websites on the Internet are
offered as a service to MMWR readers and don’t represent or suggest
endorsement of those organizations or their packages by CDC or the U.S.
Department of Health and Human Services. CDC just isn’t answerable for the content material
of pages discovered at these websites. URL addresses listed in MMWR have been present as of
the date of publication.

All HTML variations of MMWR articles are generated from closing proofs by way of an automatic course of.
This conversion would possibly lead to character translation or format errors within the HTML model.
Users are referred to the digital PDF model (https://www.cdc.gov/mmwr)
and/or the unique MMWR paper copy for printable variations of official textual content, figures, and tables.

Questions or messages relating to errors in formatting ought to be addressed to
mmwrq@cdc.gov.

[adinserter block=”4″]

[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here